Norvasc and Pre-eclampsia - a phase IV clinical study of FDA data

Summary:

Pre-eclampsia is reported as a side effect among people who take Norvasc (amlodipine besylate), especially for people who are 30-39 old, also take Folic Acid, and have Psoriasis.

The phase IV clinical study analyzes which people have Pre-eclampsia when taking Norvasc. It is created by eHealthMe based on reports of 133,505 people who have side effects when taking Norvasc from the FDA, and is updated regularly.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 136,738 Norvasc users. Check the latest studies of Norvasc.

What is Pre-eclampsia?

Pre-eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman) is found to be associated with 398 drugs and 576 conditions by eHealthMe. Check the latest studies of Pre-eclampsia.

On Jul, 08, 2026

133,505 people reported to have side effects when taking Norvasc.
Among them, 20 people (0.01%) have Pre-eclampsia.

Among these 20 people:

What is the age of people who have Pre-eclampsia when taking Norvasc? *

What are other drugs people take besides Norvasc? *

What are other side effects people have besides Pre-eclampsia? *

Drug Exposure During Pregnancy: 7 people, 35.00%
Premature Baby: 6 people, 30.00%
Birth Control: 4 people, 20.00%
Injection Site Haemorrhage (bleeding from injection site): 4 people, 20.00%
Maternal Exposure During Pregnancy (use of substance during pregnancy): 4 people, 20.00%
Hypotension (abnormally low blood pressure): 4 people, 20.00%
Stress And Anxiety: 4 people, 20.00%
Joint Stiffness: 4 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 20.00%
Anaemia (lack of blood): 4 people, 20.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 25.00%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 25.00%
Type 1 Diabetes: 2 people, 10.00%
Upper Respiratory Tract Infection: 1 person, 5.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.00%
Asthma: 1 person, 5.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 5.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 5.00%
Hypersensitivity: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and have Pre-eclampsia?

- Check whether Pre-eclampsia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Norvasc:

Norvasc (136,738 reports)

Pre-eclampsia treatments and more:

Pre-eclampsia (6,691 reports)

Browse all side effects of Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pre-eclampsia:

Pre-eclampsia (398 drugs)

Browse all the conditions that are associated with Pre-eclampsia:

Pre-eclampsia (576 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Norvasc) and Norvasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.